Patient centric measures for a patient centric era: Agreement and convergent between ratings on The Patient Global Impression of Improvement (PGI-I) scale and the Clinical Global Impressions – Improvement (CGI-S) scale in bipolar and major depressive disorder

[1]  Robert S. Huckman,et al.  Making Patients and Doctors Happier - The Potential of Patient-Reported Outcomes. , 2017, The New England journal of medicine.

[2]  M. Maes,et al.  Adjunctive minocycline treatment for major depressive disorder: A proof of concept trial , 2017, The Australian and New Zealand journal of psychiatry.

[3]  T. Koo,et al.  A Guideline of Selecting and Reporting Intraclass Correlation Coefficients for Reliability Research. , 2016, Journal Chiropractic Medicine.

[4]  M. Berk,et al.  The efficacy of adjunctive N-acetylcysteine in major depressive disorder: a double-blind, randomized, placebo-controlled trial. , 2014, The Journal of clinical psychiatry.

[5]  M. Berk,et al.  Maintenance N-acetyl cysteine treatment for bipolar disorder: A double-blind randomized placebo controlled trial , 2012, BMC Medicine.

[6]  M. Berk,et al.  The efficacy of N-acetylcysteine as an adjunctive treatment in bipolar depression: an open label trial. , 2011, Journal of affective disorders.

[7]  L. Arnold,et al.  Flexible Dosed Duloxetine in the Treatment of Fibromyalgia: A Randomized, Double-blind, Placebo-controlled Trial , 2010, The Journal of Rheumatology.

[8]  J. Speight,et al.  FDA guidance on patient reported outcomes , 2010, BMJ : British Medical Journal.

[9]  L. Cardozo,et al.  Validation of the Patient Global Impression of Improvement (PGI-I) for urogenital prolapse , 2010, International Urogynecology Journal.

[10]  K. Demyttenaere,et al.  Patient-assessed versus physician-assessed disease severity and outcome in patients with nonspecific pain associated with major depressive disorder. , 2009, Primary care companion to the Journal of clinical psychiatry.

[11]  Maurizio Fava,et al.  Does the probability of receiving placebo influence clinical trial outcome? A meta-regression of double-blind, randomized clinical trials in MDD , 2009, European Neuropsychopharmacology.

[12]  S. Targum,et al.  The clinical global impressions scale: applying a research tool in clinical practice. , 2007, Psychiatry (Edgmont (Pa. : Township)).

[13]  L. Viktrup,et al.  Comparison of physician and patient assessments of incontinence severity and improvement , 2007, International Urogynecology Journal.

[14]  Philip S. Insel,et al.  Efficacy and adverse effects of atypical antipsychotics for dementia: meta-analysis of randomized, placebo-controlled trials. , 2006, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.

[15]  Arif Khan,et al.  Relative sensitivity of the Montgomery–Åsberg depression rating scale, the Hamilton depression rating scale and the Clinical Global Impressions rating scale in antidepressant clinical trials: a replication analysis , 2004, International clinical psychopharmacology.

[16]  R. Bump,et al.  Validation of two global impression questionnaires for incontinence. , 2003, American journal of obstetrics and gynecology.

[17]  N. Polissar,et al.  Relative sensitivity of the Montgomery-Asberg Depression Rating Scale, the Hamilton Depression rating scale and the Clinical Global Impressions rating scale in antidepressant clinical trials , 2002, International clinical psychopharmacology.

[18]  M. Stewart.  Towards a global definition of patient centred care , 2001, BMJ : British Medical Journal.

[19]  M K Shear,et al.  Cognitive-behavioral therapy, imipramine, or their combination for panic disorder: A randomized controlled trial. , 2000, JAMA.

[20]  B. Rothbaum,et al.  Efficacy and safety of sertraline treatment of posttraumatic stress disorder: a randomized controlled trial. , 2000, JAMA.

[21]  J. Endicott,et al.  The Range of Impaired Functioning Tool (LIFE–RIFT): a brief measure of functional impairment , 1999, Psychological Medicine.

[22]  D. Altman,et al.  Measuring agreement in method comparison studies , 1999, Statistical methods in medical research.

[23]  M. Cantillon,et al.  A randomized double-blind study of fluoxetine versus placebo in the treatment of dysthymia. , 1993, The American journal of psychiatry.

[24]  H. Goldman,et al.  Revising axis V for DSM-IV: a review of measures of social functioning. , 1992, The American journal of psychiatry.

[25]  J Gorman,et al.  Phenelzine vs atenolol in social phobia. A placebo-controlled comparison. , 1992, Archives of general psychiatry.

[26]  M. Åsberg,et al.  A New Depression Scale Designed to be Sensitive to Change , 1979, British Journal of Psychiatry.

[27]  J. Fleiss,et al.  Statistical methods for rates and proportions , 1973 .

[28]  D. Sheehan,et al.  The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. , 1998, The Journal of clinical psychiatry.

[29]  J. Endicott,et al.  Quality of Life Enjoyment and Satisfaction Questionnaire: a new measure. , 1993, Psychopharmacology bulletin.